Partners4Access, a leading market access consultancy specializing in orphan drugs, cell and gene therapy today announced its participation at the World Orphan Drug Congress, an
Sophie Schmitz, Managing Partner of Partners4Access is to chair a panel discussion on rare diseases at the BioIndustry Association or BIA’s event UK Bioscience Forum
As part of its business expansion activities, Partners4Access’ Sophie Schmitz will be attending industry group, BioIndustry Association (BIA)’s Summer Networking Reception on Thursday, July 12.
Partners4Access has announced its membership of the UK’s leading biotechnology focused industry group, BioIndustry Association (BIA). BIA represents several stakeholders within the biosciences area from
Partners4Access has announced the appointment of Alison Kneen as Vice President of International Operations to lead its rapidly expanding Market Access Orphan Drug Specialist team.
Free webinar will be held on Wednesday April 4 2018 at 17:00 GMT/12:00 EST/9:00 PST. Registration available at https://partners4access.com/events/gene-therapy/ PARTNERS4ACCESS has announced details of its
On Rare Disease Day, we at P4A are exploring the most innovative ways to treat and cure rare diseases. This has led to the creation
Rare Disease Day infographic – US & EU February 28 is rare disease day. To be rare is to be unique. And a rare disease
New office accommodates higher headcount reflecting rapid growth for both companies Partners4Access (P4A), the global specialists in orphan drug access and Global Pricing Innovations (GPI),
